A functional ex vivo assay to detect PARP1‐EJ repair and radiosensitization by PARP‐inhibitor in prostate cancer-Reference-Cited by-同舟云学术

A functional ex vivo assay to detect PARP1‐EJ repair and radiosensitization by PARP‐inhibitor in prostate cancer

Published:2019-01-05 Issue:7 Volume:144 Page:1685-1696
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Köcher Sabrina¹,Beyer Burkhard²,Lange Tobias³,Nordquist Lena¹,Volquardsen Jennifer¹,Burdak‐Rothkamm Susanne⁴,Schlomm Thorsten²,Petersen Cordula⁴,Rothkamm Kai¹,Mansour Wael Yassin¹⁵^ORCID

Affiliation:

1. Laboratory of Radiobiology and Experimental RadiooncologyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany

2. Martini‐Klinik, Prostate Cancer CenterUniversity Medical Hamburg Eppendorf Hamburg Germany

3. Institute of AnatomyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany

4. Department of Radiotherapy and RadiooncologyUniversity Medical Center Hamburg‐Eppendorf Hamburg Germany

5. Department of Tumor BiologyNational Cancer Institute, Cairo University Cairo Egypt

Funder

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32018

Reference42 articles.

1. Estimates of the cancer incidence and mortality in Europe in 2006

2. Cancer Statistics, 2010

3. DNA Repair. Recent results in cancer research Fortschritte der Krebsforschung Progres dans les recherches sur le;Borgmann K;Cancer,2016

4. DNA double-strand break repair: From mechanistic understanding to cancer treatment

5. Pathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review);International Journal of Molecular Sciences;2023-08-19

2. Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1;Clinical and Translational Radiation Oncology;2023-07

3. Preclinical patient‐derived modeling of castration‐resistant prostate cancer facilitates individualized assessment of homologous recombination repair deficient disease;Molecular Oncology;2023-03-16

4. Experimental in vitro, ex vivo and in vivo models in prostate cancer research;Nature Reviews Urology;2022-11-30

5. Harnessing the Utility of Ex Vivo Patient Prostate Tissue Slice Cultures;Frontiers in Oncology;2022-03-31